MIRD第34号手册第1部分:MIRDct可定制CT剂量学软件工具
本文介绍MIRDsoft.org平台新开发的MIRDct软件工具,可基于用户输入的患者特征、扫描仪规格和技术参数,实现器官模型层面的CT剂量学计算与辐射风险指标评估。该工具内置24个网格型体模库(覆盖2种性别、6个年龄段、2种手臂体位)和预计算蒙特卡罗剂量系数数据库,可即时计算器官吸收剂量、有效剂量、剂量长度乘积及体型特异剂量估计,并在4种扫描协议下与NCICT和VirtualDose比较,有效剂量差异为4%–30%。
要点
- MIRDct可快速估算CT器官剂量、有效剂量及辐射风险指标。
- 内置24个网格型体模覆盖成人及儿童、男女两性与两种手臂体位。
- 与NCICT和VirtualDose比较,有效剂量差异为4%–30%。
核心结论
- MIRDct是一款集成于MIRDsoft.org平台的CT剂量学软件工具,可提供器官模型层面的剂量估算和辐射风险指标,支持CT协议优化与质量保证。
研究设计与样本
- 研究描述了MIRDct软件工具的开发与设计,该工具集成在MIRDsoft.org辐射剂量学社区平台中,基于用户输入进行计算,并与NCICT和VirtualDose在4种扫描协议下进行基准比较。
主要发现
- MIRDct利用24个网格型体模库(2种性别、6个年龄段、2种手臂体位)和预计算蒙特卡罗剂量系数数据库,可即时计算器官吸收剂量、有效剂量、剂量长度乘积和体型特异剂量估计。
- MIRDct还提供损害加权剂量、终生归因风险和风险指数等风险相关指标,并可选做不确定度量化与误差传播。
- 与NCICT和VirtualDose在4种扫描协议下比较,有效剂量差异为4%–30%。
关键数值与推荐
- 有效剂量与NCICT和VirtualDose比较差异为4%–30%(4种扫描协议)。
- 体模库覆盖2种性别、6个年龄段、2种手臂体位,共24个网格型体模。
临床怎么用
- 核医学科可用MIRDct评估PET/CT和SPECT/CT中CT所致患者剂量,优化扫描协议并满足法规与科研受试者保护要求。
局限性
- 摘要未报告软件在临床真实扫描条件下的验证结果,比较仅涉及NCICT和VirtualDose两种软件及4种扫描协议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
X-ray CT has long played a critical role in diagnostic radiology and is also a fundamental component of hybrid imaging in nuclear medicine, providing essential information for anatomic localization of radiopharmaceutical uptake and attenuation correction for PET/CT and SPECT/CT studies. Notably, the radiation dose to the patient from CT can be comparable to or exceed that of the administered radiopharmaceutical, underscoring the need for accurate CT dosimetry to optimize imaging protocols. With the increasing use of CT worldwide in both diagnostic radiology and nuclear medicine, robust tools are needed to assess patient radiation dose and to satisfy regulatory and human-subject research requirements. To address these needs, we developed MIRDct, a software tool integrated within the MIRDsoft.org radiation dosimetry community platform. The code offers organ model-based CT dosimetry and radiation risk metrics tailored for radiology and nuclear medicine applications. MIRDct relies on user-defined inputs for patient characteristics, scanner specifications, and technique parameters to provide rapid and accurate organ-level dose estimates. The software features built-in scan protocols with scan ranges based on predefined anatomic landmarks and supports user-defined custom scan ranges through an intuitive graphic interface. The code leverages a library of 24 state-of-the-art mesh-type phantoms modeling representative adult and pediatric patients of both sexes, configured in either arms-up or arms-down positioning (2 sexes, 6 ages, 2 arm positions). A precomputed Monte Carlo-based dose-coefficient database derived for this library enables instantaneous computation of organ-absorbed doses, effective dose, dose-length product, and size-specific dose estimates. MIRDct also provides risk-related metrics, including detriment-weighted dose, lifetime attributable risk, and risk index, and incorporates optional uncertainty quantification and error propagation to provide a quantitative indicator of estimate reliability. Dose estimates from MIRDct were benchmarked and compared across 4 scan protocols with other available codes (the National Cancer Institute dosimetry system for computed tomography and VirtualDose), demonstrating reasonable agreement (4%-30% differences for effective dose). Version 1.1, available at MIRDsoft.org, presents all underlying calculations through a transparent spreadsheet-based implementation and offers advanced features to support CT protocol optimization, deepen dosimetry insight for patient-care-related evaluations, and aid in quality assurance.
引用
- Ocampo Ramos JC, Kofler C, Dawson R, et al. MIRD Pamphlet No. 34, Part 1: MIRDct-A Customizable Software Tool for CT Dosimetry. J Nucl Med. 2026. PMID: 41679920. doi:10.2967/jnumed.125.270494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。